Dr. Wafik El-Deiry, MD, PhD, FACP

Media Releases

Dr. El-Deiry, a Leading Authority in Oncology, Continues to Revolutionize Cancer Treatment Strategies and Patient Care

An esteemed figure in the medical world, Dr. El-Deiry has garnered recognition for his outstanding contributions to the field of oncology. As the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and the Director of the Cancer Center at Brown University, he plays a pivotal role in shaping the future of cancer research and patient care. His leadership extends to overseeing the Joint Program in Cancer Biology, a collaborative initiative involving Brown University and affiliated hospitals, aimed at fostering interdisciplinary research and enhancing clinical outcomes.

With a distinguished background that combines medical expertise and significant research achievements, he has made remarkable strides in understanding cancer biology and developing innovative treatment approaches. Specializing in the care of patients with colorectal cancer and rare genetic drivers of other tumor types, he is a driving force in advancing oncologic sciences.

Boasting an impressive educational background that includes MD and PhD degrees from the University of Miami School of Medicine, Dr. El-Deiry completed his medical training at prestigious institutions such as the Johns Hopkins Hospital and the Johns Hopkins Oncology Center. His expertise has been further recognized through his appointment as an American Cancer Society Research Professor, solidifying his reputation as a leading expert in the oncology field.

His impactful research has led to groundbreaking discoveries in cancer biology, notably his pioneering work in defining the genomic DNA-binding consensus sequence for the p53 tumor suppressor protein. His identification of p53 target genes and the CDK inhibitor p21(WAF1) has significantly advanced our understanding of tumor suppression mechanisms and cell cycle regulation, leading to the development of FDA-approved CDK inhibitor drugs that have revolutionized cancer therapy.

Throughout his illustrious career, Dr. El-Deiry has held key positions at esteemed institutions, including the University of Pennsylvania School of Medicine, where he served as a Professor of Medicine, Pharmacology, and Genetics. His tenure as a Howard Hughes Medical Institute Investigator further underscores his exceptional contributions to biomedical research, inspiring the next generation of oncologists and researchers.

Dr. El-Deiry's relentless dedication to translating cutting-edge research into tangible clinical outcomes continues to shape the landscape of oncology, offering hope to patients and driving progress in the fight against cancer.

Recommended Articles

• Potential New Target Found for Ovarian Cancer Treatment

  Being diagnosed with any form of cancer is a scary event that can turn a person’s world upside down. While cancer is never good, there are certain forms of the disease that are more threatening than others.When it comes to women, especially post-menopausal women, endometrial cancer can be one of...

• Rate of Mastectomies Rose After Angelina Jolie Publicized Her Decision

  In 2013, Angelina Jolie announced her decision to have preventative double mastectomies. At that time, she had discovered that she was a carrier of the BRCA1 gene mutation, which increased her risk of both breast and ovarian cancer.In just 2 short years following her mastectomies, she also had her...

• What Are the Signs and Symptoms of Liver Cancer?

  Liver cancer is a condition that is characterized by the abnormal or cancerous growth of liver cells. Liver cells are also called as hepatocytes. Hence, liver cancer can also be called as hepatocellular cancer. Although other cell types can become cancerous, the most common cause of liver cancer is...

• What Are Petechiae?

  What Are Petechiae?Petechiae can be described as marks or blotches that normally appear on the skin and are tiny, round, and purplish or reddish in color. Petechiae are usually pinpoint-sized. Minor hemorrhage (bleeding that is localized below the skin) is the source of petechiae.Although they...

• This Ovarian Cancer Survivor Advises Women to Stay True to Themselves

  Those who have been through cancer often have some of the best advice on how to live life, as they have come so close to losing their own. This often creates an ability to distinguish what is important and what isn't, and Pam Scarpino now knows what is most important: staying true to oneself.Pam's...

• Red Carpet Host Giuliana Rancic Opens Up About Breast Cancer

  Breast cancer is a battle that isn't easy for any woman. For Giuliana Rancic, she knows this firsthand. The Live From the Red Carpet host is a breast cancer survivor who now dedicates herself to helping other women who are battling cancer too. She started an organization called Fab-U-Wish, which...